Investors & Media
Medical Affairs
Contact

Investors & Media

At Vera Therapeutics, our mission is to pursue truth in science to transform medicine in autoimmune diseases, starting with kidney disease.

Stock Information

Minimum 15 minutes delayed. Source: LSEG

View more

Corporate Presentation

Download

Latest Press Releases

Jun 5, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 2, 2026

Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy

May 8, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Events & Presentations

Mar 3, 2026 11:10 AM EST

TD Cowen 46th Annual Health Care Conference

Jan 13, 2026 2:15 PM PST

44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025 4:00 PM EST

Citi 2025 Global Healthcare Conference

Contact

INVESTOR INQUIRIES

IR@veratx.com

MEDIA INQUIRIES

corporatecommunications@veratx.com

Leaving this site

The link will take you to a third-party site and is not owned or controlled by Vera. Vera makes no representation as to the accuracy of the information contained on third-party sites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.